TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: cognitive improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Proportion of patients in remission
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Detection of malingerers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hamilton Depression Rating Scale score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Global Depression score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Brief Psychiatric Rating Scale score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Inactive state (Alertness Observation Checklist)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HRV (Heart Rate Variability)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Disease stability associated with rash occurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CD4+/CD8+ ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean postoperative drain output
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: hemoglobin drop at Day 2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Successful outcome (cyst volume ≤ 1 mL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in solid nodule volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in median visual analog score for pressure symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HIV-1 viral load less than 400 copies/ml at the time of delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Time to return to baseline functional status
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: extensor trunk muscle strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Asthma severity/control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Emergency department visits for asthma
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Maternal bradycardia episodes
Endpoint domain: Adverse events/effects
Primary endpoint: Identification of suicidal events
Endpoint domain: Adverse events/effects
Primary endpoint: Agreement on suicide attempts
Endpoint domain: Adverse events/effects
Primary endpoint: Reliability of C-CASA ratings
Endpoint domain: Adverse events/effects
Primary endpoint: Time before administration of the first dose of analgesic postoperatively
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Requirement for analgesics in the first 9 hours postoperatively
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mortality due to cardiovascular causes
Endpoint domain: Mortality/survival
Primary endpoint: Reduction of erythema area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Proportion of patients with viral load below 50 copies/mL at week 24
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: water content in skin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: LARC method use at 3 months postpartum
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dyspnea numeric rating scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lung insufflation capacities
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Assisted cough peak flows
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: myocardial blood flow (MBF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Availability of autologous products
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: combined clinical end point of death/reinfarction
Endpoint domain: Mortality/survival
Primary endpoint: cumulative cardiac event‐free survival rate
Endpoint domain: Mortality/survival
Primary endpoint: Proportion of bacteriologically confirmed TB cases not initiating TB treatment by 3 mo after presentation
Endpoint domain: Mortality/survival
Primary endpoint: Grade 3/4 Toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: incidences of adverse effects
Endpoint domain: Adverse events/effects
Primary endpoint: overall patients' satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Medication intolerance
Endpoint domain: Adverse events/effects
Primary endpoint: Eradication rates for H pylori
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: incidence of actinic keratosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Progression to constitutional symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: perioperative serum interleukin-8 values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: concentrations of plasma RBC microvesicles
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: plasma cell-free haemoglobin concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: therapist adherence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Progression-free median survival
Endpoint domain: Mortality/survival
Primary endpoint: Death or recurrent nonfatal MI
Endpoint domain: Mortality/survival
Primary endpoint: Attendance at first aftercare appointment
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Duration of rupture of membrane to delivery interval
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oxytocin requirement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: relative ROM in adjacent caudal segment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in melanin index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Improvement in overall fairness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Vaginal discharge associated with symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence of yeast detected by culture
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: venous thromboembolism
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Endoscopic healing rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Effective rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Total time of pH < 4
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Summed pain intensity difference (SPID) over 60 minutes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete abolition of pain 60 minutes after medication
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tensile strength of small intestinal anastomoses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Acute Kidney Injury
Endpoint domain: Adverse events/effects
Primary endpoint: seroconversion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incident heart failure (HF)
Endpoint domain: Mortality/survival
Primary endpoint: Physical function (KQOLS)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Pain (KQOLS)
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Proportion of calls to the Helpline
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: incidence of constipation, leg cramp or joint pain and prolonged lochia rubra
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HbA1c effectiveness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Intake of loperamide
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: new cutaneous malignancies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: prolonged adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: three-month mortality
Endpoint domain: Mortality/survival
Primary endpoint: twelve-month mortality
Endpoint domain: Mortality/survival
Primary endpoint: Improved health management
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Antibacterial activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Screening attendance rates
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Reliability of ankle swelling measurement methods
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fragmentation success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Degree of hypothermia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Facial affect recognition accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual analogue scale assessments
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum IL-16 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Perception of outdoor play frequency
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean change in total cholesterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean change in low-density lipoprotein cholesterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean change in high-density lipoprotein cholesterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: negative appendectomy percentage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: perforation rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-efficacy in asthma attack prevention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Self-efficacy in management during asthma attacks
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: sustain a moderate to severe injury
Endpoint domain: Adverse events/effects
Primary endpoint: Area under the curve (AUC) of ENG
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum concentration (Cmax) of ENG
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Minimum concentration (Cmin) of ENG
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean distance of irrigant delivery to WL of root canals
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean lung deposition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: nebulization time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perceived learning in history taking and physical examination
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Perceived learning in record keeping and disease management
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percentage of patients ready for discharge
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: humoral response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: severe toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Total urinary symptom scores (IPSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average flow rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postvoid residual volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Drug concentration in tissues
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Need for functional endoscopic sinus surgery (FESS)
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Late CRSnNP recurrence
Endpoint domain: Adverse events/effects
Primary endpoint: weekly MPS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ≥50% responders at endpoint
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of red blood transfusions in first 28 days of life
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Admission temperatures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood pressures during the first 24 hours of life
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Verbal analogue pain scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: proportion of players with ultrasonographic changes in the patellar tendons
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: risk of developing tendon symptoms during the season
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Resolved disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Circulating metabolites associated with prostate cancer presence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Primary outcome occurrence in patients undergoing vascular surgery
Endpoint domain: Mortality/survival
Primary endpoint: Bayley III score at 24 months corrected age
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: failed ligament reconstructions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Times until walking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Discharge home
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improving self-care ability
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Reducing risk for Alzheimer's disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reducing risk for osteoporosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: target website activity
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: ETAM scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Improvements in function detected by the LE CP‐CAT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SPPB-Total Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional classification improvement
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Program satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of family members registered in family groups
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Professional empowerment
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Improvements in major symptoms of OAB
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient satisfaction with solifenacin tolerability
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Patient satisfaction with solifenacin efficacy
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Score on the maintenance of certification examination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Attendance for OGTT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fasting plasma glucose completion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HbA1c completion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Basal plasma ACTH levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: 24 h urinary cortisol excretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: MAI (%) induced by ADP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Therapeutic potential in overactive bladder
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physical Activity during Recess
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean differences in intraocular pressure (IOP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Repeatability coefficients of IOP measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inter-observer reproducibility of IOP measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Expression of CD40L, CD11b, CD54 on monocytes and neutrophils
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Expression of CD11a on monocytes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: HIV drug risk scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Periods of MAP < 65 mmHg
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean graft obliquity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: acute-onset noncontact LE injuries
Endpoint domain: Adverse events/effects
Primary endpoint: noncontact ankle sprains
Endpoint domain: Adverse events/effects
Primary endpoint: noncontact knee sprains
Endpoint domain: Adverse events/effects
Primary endpoint: Serum concentration of hsCRP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: arterial ADMA levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time of return to work
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Reversal of hypoxemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knowledge about healthy food
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Self-reported behaviour regarding soft drinks
Endpoint domain: Life impact
Endpoint subdomain: Behavioural functioning
Primary endpoint: Mean CSF Aβ(1‐x) increase from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain and analgesic scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Interruption in the operation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Need for wound haemostasis of the access ports
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Pain intensity in neck, shoulders, arms/wrists
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: MEP threshold
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: response rate of pleural effusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in periorbital wrinkles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Success rate of Microwave Endometrial Ablation (MEA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amenorrhea rate after Microwave Endometrial Ablation (MEA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: depressive relapse
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: plasma free and total tryptophan levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Immunization rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Likelihood of having a primary care physician
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional status (IADL) scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Annual rate of eGFR decline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Rate of growth in total kidney volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Fever monitoring and treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hyperglycemia monitoring and treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Swallowing assessment and confirmation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes